MTCH2 and colorectal carcinoma: To determine the clinical significance of MTCH2 in CRC patients, we performed immunohistochemical (IHC) staining on CRC tissue arrays using an anti‐MTCH2 antibody, whose specificity was validated in MTCH2 knockout RKO cells (Figure S1, Supporting Information).